These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 18288180)

  • 1. Triggers, targets and treatments for thrombosis.
    Mackman N
    Nature; 2008 Feb; 451(7181):914-8. PubMed ID: 18288180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New anticoagulant drugs.
    Weitz JI
    J Thromb Thrombolysis; 2001 Sep; 12(1):7-17. PubMed ID: 11711683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis.
    Berry CN; Lunven C; Lechaire I; Girardot C; O'Connor SE
    Br J Pharmacol; 1998 Sep; 125(1):29-34. PubMed ID: 9776340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular disease.
    Husmann M; Barton M
    Expert Opin Investig Drugs; 2007 May; 16(5):563-7. PubMed ID: 17461731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New targets for antithrombotic drugs.
    Thiagarajan P
    Am J Cardiovasc Drugs; 2002; 2(4):227-35. PubMed ID: 14727968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update on new antithrombotic treatments].
    Boehlen F; Tirefort-Dimitrova Y; de Moerloose P; Fontana P
    Rev Med Suisse; 2010 Jan; 6(232):109-12. PubMed ID: 20170027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized antithrombotic therapy.
    Lüscher TF; Steffel J
    Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifty years of research on antithrombotic therapy: Achievements and disappointments.
    Hirsh J; Eikelboom JW; Chan NC
    Eur J Intern Med; 2019 Dec; 70():1-7. PubMed ID: 31679885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to the treatment of thrombosis.
    Gresele P; Agnelli G
    Trends Pharmacol Sci; 2002 Jan; 23(1):25-32. PubMed ID: 11804648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Badimon Perfusion Chamber: An Ex Vivo Model of Thrombosis.
    Zafar MU; Santos-Gallego CG; Badimon L; Badimon JJ
    Methods Mol Biol; 2018; 1816():161-171. PubMed ID: 29987818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-modulatory effects of clopidogrel and heparin on platelet and fibrin incorporation in thrombosis.
    Cooley BC; Herrera AJ
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):593-8. PubMed ID: 23492917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic approaches to combat arterial thrombosis: better drugs for old targets, novel targets, and future prospects.
    Choi J; Kermode JC
    Mol Interv; 2011 Apr; 11(2):111-23. PubMed ID: 21540471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokines and thrombosis.
    Schäfer K; Konstantinides S
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):864-71. PubMed ID: 21848866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent thrombosis in 2008: definition, predictors, prognosis and treatment.
    Lemesle G; Delhaye C; Bonello L; de Labriolle A; Waksman R; Pichard A
    Arch Cardiovasc Dis; 2008; 101(11-12):769-77. PubMed ID: 19059572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Agents.
    Chan NC; Weitz JI
    Circ Res; 2019 Feb; 124(3):426-436. PubMed ID: 30702990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute thrombosis of a mesenteric artery drug-eluting stent following clopidogrel cessation.
    Sutphin D; Stevens S; Kirzeder D; Gash J
    Vasc Endovascular Surg; 2007 Dec-2008 Jan; 41(6):564-7. PubMed ID: 18166642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panel discussion.
    Shigematsu H; Uchiyama S; Goto S
    Drugs; 2010 Nov; 70 Suppl 1():15-22. PubMed ID: 20977288
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis.
    Petzold T; Thienel M; Konrad I; Schubert I; Regenauer R; Hoppe B; Lorenz M; Eckart A; Chandraratne S; Lennerz C; Kolb C; Braun D; Jamasbi J; Brandl R; Braun S; Siess W; Schulz C; Massberg S
    Sci Transl Med; 2016 Nov; 8(367):367ra168. PubMed ID: 27903864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia with thrombosis after endovascular aneurysm repair.
    Kolluri R; Rocha-Singh K; Sarac T; Bartholomew JR
    Vasc Endovascular Surg; 2009; 43(1):89-92. PubMed ID: 18799498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future directions in antithrombotic therapy: emphasis on venous thromboembolism.
    Axelrod DA; Wakefield TW
    J Am Coll Surg; 2001 May; 192(5):641-51. PubMed ID: 11333101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.